Skip to content

Ultra Flora LGG 60 caps

This is a practitioner-only product. Please arrange a telephone consultation with our health care practitioners to ensure this product is suitable for you.

Metagenics Ultra Flora LGG provides:
  • For a wide range of microbiome clinical protocols and for immune conditions and gastrointestinal function.
  • Contains the authentic LGG® strain and supply chain, with over 20 years of clinical research.
  • No refrigeration required - remains full strength for the length of shelf life (when stored below 25°C), for improved patient compliance.
  • Dairy free.

Each capsule contains:


Lactobacillus rhamnosus (LGG®)

10 billion CFU (organisms)

Free from animal products, dairy protein, lactose, eggs, gluten, wheat, nuts, yeast, soy protein and salt. Free from artificial colours, flavours and preservatives.

LGG® is a registered trademark of Chr. Hansen A/S.

Immunological Use: Immune support: LGG® is immune modulating with the lower dose range (1 billion – 10 billion CFU) supporting immune response and has been shown to reduce upper respiratory tract infections (URTIs) and colds (particularly in children).
Allergy: Higher doses of LGG®(20 billion CFU ) have been shown to up regulate anti-inflammatory interleukins (IL-10) and down regulate ImmunoglobulinE (IgE) synthesis.7 In addition to a significant amount of research in infants and prenatally, a 2015 clinical trial showed a reduction in peanut allergy in children when used in conjunction with a desensitisation program. Metagenics supports Professor Mimi Tang’s research in childhood food allergy at the Murdoch Children’s Research Institute and are product suppliers for a follow-up study in peanut allergy.
Gastrointestinal Use: Diarrhoea:LGG® (10-20 billion CFU) reduces the frequency, severity and duration of diarrhoea – viral, travellers and also antibiotic associated.

Microbiome Use: Regeneration of core commensal (native) gut flora: More recently DNA sequencing of the microbiome has shown LGG® has the ability to influence and regenerate commensal bacterial families.

Prenatal Use: LGG® has a wide body of evidence showing reduced allergy, eczema and atopy when taken prenatally. More recent research has shown support for maternal glucose control, maternal and childhood obesity and reduced incidence of childhood behavioural complaints (when taken during pregnancy and infancy)